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Background: Intensive care unit-acquired weakness (ICUAW) is a common complication, associated with significant
morbidity. Neuromuscular electrical stimulation (NMES) has shown promise for prevention. NMES acutely affects
skeletal muscle microcirculation; such effects could mediate the favorable outcomes. However, optimal current
characteristics have not been defined. This study aimed to compare the effects on muscle microcirculation of a
single NMES session using medium and high frequency currents.
Methods: ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis of three to five days
duration and patients with ICUAW were studied. A single 30-minute NMES session was applied to the lower limbs
bilaterally using current of increasing intensity. Patients were randomly assigned to either the HF (75 Hz, pulse
400 μs, cycle 5 seconds on - 21 seconds off) or the MF (45 Hz, pulse 400 μs, cycle 5 seconds on - 12 seconds off)
protocol. Peripheral microcirculation was monitored at the thenar eminence using near-infrared spectroscopy (NIRS)
to obtain tissue O2 saturation (StO2); a vascular occlusion test was applied before and after the session. Local
microcirculation of the vastus lateralis was also monitored using NIRS.
Results: Thirty-one patients were randomized. In the HF protocol (17 patients), peripheral microcirculatory
parameters were: thenar O2 consumption rate (%/minute) from 8.6 ± 2.2 to 9.9 ± 5.1 (P = 0.08), endothelial reactivity
(%/second) from 2.7 ± 1.4 to 3.2 ± 1.9 (P = 0.04), vascular reserve (seconds) from 160 ± 55 to 145 ± 49 (P = 0.03). In
the MF protocol: thenar O2 consumption rate (%/minute) from 8.8 ± 3.8 to 9.9 ± 3.6 (P = 0.07), endothelial reactivity
(%/second) from 2.5 ± 1.4 to 3.1 ± 1.7 (P = 0.03), vascular reserve (seconds) from 163 ± 37 to 144 ± 33 (P = 0.001).
Both protocols showed a similar effect. In the vastus lateralis, average muscle O2 consumption rate was 61 ± 9%/
minute during the HF protocol versus 69 ± 23%/minute during the MF protocol (P = 0.5). The minimum amplitude
in StO2 was 5 ± 4 units with the HF protocol versus 7 ± 4 units with the MF protocol (P = 0.3). Post-exercise, StO2
increased by 6 ± 7 units with the HF protocol versus 5 ± 4 units with the MF protocol (P = 0.6). These changes
correlated well with contraction strength.
Conclusions: A single NMES session affected local and systemic skeletal muscle microcirculation. Medium and high
frequency currents were equally effective.
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The development of muscle weakness is a frequent oc-
currence in ICU patients. Both nerve and muscle dys-
function can be responsible for this clinical condition,
variably known as critical illness neuropathy, critical ill-
ness myopathy, and ICU-acquired weakness (ICUAW)
among other terms, and is presumably a complication of
sepsis [1,2]. Patients with ICUAW are prone to have dif-
ficult weaning from mechanical ventilation and to have a
longer duration of ICU stay, with all the associated risks
[3,4]. Even after discharge, patients can have severely im-
paired muscle force for months or years, with significant
repercussions on their quality of life [5,6].
With no treatment available, emphasis has been placed
on finding effective preventive measures. Early patient
mobilization has been increasingly adopted, since it has
been shown to produce better outcomes with regard to
muscle strength and functionality [7]. Since active
mobilization is not feasible for many ICU patients, due to
either their illness or sedation, neuromuscular electrical
stimulation (NMES) has been proposed as an alternative
method of exercise and mobilization. This approach was
based on clinical experience in patients with chronic ob-
structive pulmonary disease (COPD) [8,9] and chronic
heart failure [10]. Initial application of NMES in septic pa-
tients using electrical currents with frequencies in the
range of medium (45 to 50 Hz) to high (100 Hz) has
shown encouraging results in preventing loss of muscle
mass and preserving strength in the critically ill [11-15].
In addition, a single session of NMES-induced exercise
using medium frequency current (45 Hz) has been shown
to acutely induce systemic changes in skeletal muscle
microcirculatory function, as assessed with near-infrared
spectroscopy (NIRS). It has been suggested that these
changes could mediate the beneficial effects of NMES on
the skeletal musculature [16]. It is not known if high fre-
quency NMES has comparable effects on the systemic
microcirculation of skeletal muscle. As a result, the NMES
characteristics of choice for critically ill patients are still
undefined, and a comparison of the effects on skeletal
muscle microcirculation is an important component in
the assessment of efficacy of the different types.
The primary aim of this study was to compare the
changes in systemic and local skeletal muscle microcir-
culation during a single session of medium frequency
NMES and a single session of high frequency NMES on
the lower limbs of critically ill patients. As secondary ob-
jectives, the effects of NMES on the microcirculation
specifically in the presence of ICUAW were examined.
Methods
Patient selection
Two distinct groups of patients were enrolled in the
study. Patients eligible for the first group (referred fromthis point on as the ‘acute group’) had to meet the diag-
nostic criteria for the systemic inflammatory response
syndrome (SIRS) or sepsis of any severity [17] for a
minimum of three and a maximum of five days at the
day of the session. These time constraints were selected
because they represent the minimum time period in
which ICUAW can develop [18]. Exclusion criteria were
age under 18 years, pregnancy, pre-existing neuromus-
cular disease, conditions that limit lower limb mobility
(for example, burns, fractures), pacemakers, and pres-
ence of edema or subcutaneous fat that interfered with
the application of NMES or with the assessment of the
microcirculation.
The second group consisted of patients who had de-
veloped clinically manifest ICUAW. These will subse-
quently be referred to as the ‘ICUAW group’. The
diagnosis of ICUAW was made on clinical grounds after
the patients had been awaken from sedation and their
orientation and cooperation had been ascertained, fol-
lowing a protocol described previously [11,19].
Study design
This was a prospective, randomized pilot study. The
study protocol was approved by the Scientific Commit-
tee of Evangelismos Hospital. Written informed consent
to participate in the study was provided by all patients
or their next of kin.
In all patients, demographic and clinical data were re-
corded, as were medications, sedative agents and ventila-
tion mode used on the day of the NMES session. Vital
signs, arterial oxygenation, central venous oxygen satur-
ation and lactate levels were obtained before and after
the NMES session. Creatine kinase (CK) levels were
monitored for four days following the application of
NMES.
NMES application and evaluation of muscle contractions
NMES was applied to both lower limbs of the patients.
An electronic stimulator (Cefar Rehab Pro, Cefar Med-
ical AB, Malmö, Sweden) was used for the application.
After appropriate skin preparation, rectangular adhesive
electrodes (9 × 5 cm) were placed over the motor points
of the vastus lateralis, vastus medialis and peroneus
longus muscles.
Patients were randomly assigned to one of two NMES
protocols. The HF (high frequency) protocol consisted
of symmetric, biphasic, trapezoid pulses at 75 Hz, with
pulse duration of 400 μs, duty cycle of 5 seconds on and
21 seconds off, ramp-up time of 1.5 seconds and ramp-
down time of 0.8 seconds. The MF (medium frequency)
protocol consisted of symmetric, biphasic, trapezoid
pulses at 45 Hz, with pulse duration of 400 μs, duty
cycle of 5 seconds on and 12 seconds off, ramp-up time
of 1.5 seconds and ramp-down time of 0.8 seconds. The
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cols, with an additional 5-minute warm-up and a 5-
minute recovery phase using 10 Hz current of 400 μs
pulse duration.
The specific waveforms were selected because they
have been shown to maximize force and delay fatigue,
compared with other forms such as the sinusoidal
[20,21]. Frequencies and duty cycles were combined
based on results from a study which specifically investi-
gated optimal combinations of NMES settings [22].
Current intensity was continually adjusted during each
session. It has been known that when a muscle group is
stimulated with constant intensity, the generated torque
gradually decreases [22,23]. In a set of preliminary trials,
we verified that the need to increase the administered
intensities is also true for the two NMES protocols
under investigation (data not shown). As a result, in
alert patients, current intensity was initially set to the
maximal tolerated level, and was increased by 10% (or
less, if the patient felt discomfort) every three minutes.
In sedated patients, after the warm-up, the intensity that
produced a maximal response was determined, and the
60% of that value was used as the starting point. In this
case also current intensity was increased by 10% every
three minutes.
Muscle contractions of the quadriceps muscles were
graded by one of the researchers, who had no know-
ledge of which protocol was being used. A score was
given according to the following scale: 0 = no contrac-
tion, 1 = palpable contraction, 2 = visible contraction,
3 = slight knee extension against gravity, 4 = full knee
extension [24].
Near-infrared spectroscopy and the vascular occlusion
technique
NIRS is used to estimate the concentration of specified
chromophores in a given tissue volume. In clinical set-
tings, the parameter of interest is the degree of
hemoglobin oxygenation, termed tissue oxygen satur-
ation (StO2). This quantity is evaluated at the microcir-
culatory compartment, according to principles described
previously [25,26].
We used a continuous-wave spectrometer (Hutchinson
InSpectra Model 650, Hutchinson Technology, Hutchinson,
MN, USA). This device emits light in four wavelengths
and uses a wide gap second-derivative method to esti-
mate StO2 with a measurement depth of 15 mm [27].
NIRS measurements were continuously recorded at
two distinct sites. A probe was placed over the thenar
eminence in order to capture the effects of NMES on
the systemic microcirculation. In addition, the vascular
occlusion technique (VOT) was applied in order to re-
veal features of the microcirculation that the simple
monitoring cannot provide. The VOT consists ofapplying a standardized ischemic stimulus to the upper
extremity by inflating a pneumatic cuff to 50 mmHg
above the systolic pressure and maintaining it for three
minutes. After that the cuff is released and perfusion is
reestablished.
During the ischemic phase, the StO2 signal decreases.
Its slope, expressed in % units per minute (downslope,
%/minute), has been shown to be a proxy for local
muscle O2 consumption rate [28]. During the reperfu-
sion phase, the StO2 signal rapidly increases, usually to a
value higher than the initial one, and then gradually
returns to baseline. The initial increase of the signal,
expressed in % units per second (upslope, %/second), is
an index of endothelial reactivity, while the duration of
the hyperemic phase reflects vascular reserve [29].
A second NIRS probe was placed over the vastus later-
alis muscle, in a randomized manner with regards to
side. The parameters that were evaluated were the StO2
desaturation slope (ΔStO2slope), which was calculated as
the average of the slopes of the StO2 signal in each con-
traction and which serves as an index of muscle O2 con-
sumption [30,31], the StO2 minimum amplitude
(ΔStO2min), which is the difference between the mini-
mum StO2 value during a contraction and baseline StO2
and is an index of O2 demand relative to O2 supply
[31,32], and the StO2 maximum amplitude (ΔStO2max),
which is the difference between the maximum StO2
value during the recovery period and baseline StO2, with
higher values indicating increased O2 supply relative to
O2 demand [32].
All NIRS measurements were stored and analyzed off-
line using the proprietary software Hutchinson InSpectra
Analysis v. 2.4 (Hutchinson Technology, Hutchinson,
MN, USA), running in Matlab v. 7.0 (The MathWorks
Inc., Natick, MA, USA).
Statistical analysis
Continuous variables are expressed as mean ± standard
deviation. Ordinal variables are expressed as median and
interquartile range (IQR). Comparisons were made using
Mann–Whitney U-test for independent samples and
Wilcoxon’s signed rank test for dependent samples. Cor-
relations were estimated using Spearman’s rank correl-
ation coefficient. Categorical variables were compared
with Fisher’s exact test. P values < 0.05 were considered
statistically significant.
Linear regression models were used to evaluate the
impact of predictor variables on continuous outcome
variables. Model comparison was made using Akaike’s
Information Criterion (AIC) to evaluate which predic-
tors were more closely associated with the outcome
[33,34].
All analyses were performed using IBM SPSS 20 for
Windows (IBM Corp., Armonk, NY, USA).
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A total of 31 patients were included in the study (26 men,
age 59 ± 11 years, with Acute Physiology and Chronic
Health Evaluation II (APACHE II) score 18 ± 6 and Se-
quential Organ Failure Assessment (SOFA) score 7 ± 2 on
the day of the NMES session). Basic characteristics of pa-
tients for the two NMES protocols are shown in Table 1.
Hemodynamic parameters were mildly affected during
NMES application: heart rate, systolic and diastolic blood
pressure were slightly increased. This effect was observed
with both protocols and had no clinical importance. Blood
lactate levels showed a moderate increase in the two
NMES protocols (Table 2). In every occasion, the magni-
tude of these effects was similar in the two protocols.
NMES was well tolerated by the patients, and no adverse
effects were noted during the application of NMES or in
the follow-up period. CK levels did not increase during the
four days following the NMES session (data not shown).
Systemic microcirculation
The parameters of the systemic microcirculation before
and after the NMES session for the HF and the MF
protocol are shown in Table 3. StO2 decreased veryTable 1 Basic characteristics of the 31 critically ill
patients by neuromuscular electrical stimulation (NMES)
protocol
HF protocol MF Protocol
(n = 17) (n = 14)
Age (years) 57 ± 12 63 ± 12
Sex 15♂/2♀ 11♂/3♀
SOFA score at admission 7 ± 3 7 ± 4
APACHE II score at admission 21 ± 7 18 ± 8
SOFA score at NMES session 7 ± 2 7 ± 3
APACHE II score at NMES session 16 ± 7 19 ± 6
Mechanical ventilation
VC/PS/VM 5/7/5 6/5/3
Sedation (n) 9 11
Admission diagnosis
Respiratory infection (n) 4 3
Sepsis (n) 3 3
COPD exacerbation (n) 0 1
Head trauma (n) 3 3
Multiple trauma (n) 3 1
Drug overdose (n) 1 0
Intracerebral hemorrhage (n) 2 2
Pancreatitis (n) 1 0
Patients with ICUAW (n) 7 5
APACHE II = Acute Physiology and Chronic Health Evaluation II; HF = high
frequency; ICUAW = intensive care unit-acquired weakness; MF =medium
frequency; PS = pressure support; SOFA = Sequential Organ Failure Assessment;
VC = volume control; VM = Venturi mask.slightly, by 1.6 ± 2.9 units and 0.9 ± 3.7 units, respect-
ively. StO2 downslope increased in both protocols, by
1.2 ± 3.7%/minute and 1.1 ± 1.7%/minute, respectively,
although these changes did not reach statistical signi-
ficance. StO2 upslope also increased by 0.56 ± 0.83%/
second and 0.52 ± 0.92%/second. This effect did not dif-
fer between the two protocols (P = 0.9). Duration of
hyperemia was also affected: the time to baseline was re-
duced by 15 ± 26 seconds and 19 ± 16 seconds. Again
this reduction did not differ significantly between the
two protocols (P = 0.6).
The parameters of the systemic microcirculation be-
fore and after the NMES session for the acute and the
ICUAW groups are shown in Table 4. In both patient
groups, StO2 upslope and time to baseline were modified
by the application of NMES in a statistically significant
degree, while this was not the case for the StO2 down-
slope. The combined effects of NMES protocol and pa-
tient group in the measured microcirculatory parameters
are shown In Figures 1, 2, 3 and 4.
Current intensity and muscle contractions
The current intensity applied at the start of the NMES
session was 57 ± 22 mA in the HF group and 63 ±
24 mA in the MF group (P = 0.4). By the end of the ses-
sion the intensities had been raised to 87 ± 37 mA and
99 ± 36 mA, respectively (P = 0.3). The increase in
current intensity that was achieved during the NMES
session was 32 ± 18 mA with the HF protocol and 38 ±
17 mA with the MF protocol (P = 0.35 for the compari-
son of the two protocols). The muscle contractions that
were elicited from the quadriceps muscle had a median
rating of 2 and IQR of 2 with the HF protocol, and also
a median rating of 2 and IQR of 2 with the MF protocol
(P = 0.6 for the comparison of the two protocols).
When the two groups of patients were compared, pa-
tients in the acute group and those in the ICUAW group
reached similar current intensities, with increases in in-
tensity of 32 ± 18 mA and 40 ± 16 mA, respectively (P =
0.2 for the comparison). On the other hand, and in line
with their diagnosis, patients in the ICUAW group de-
veloped less intense muscle contractions in the lower
limbs than patients in the acute group for comparable
current intensities: median 1.5 with IQR 2 versus median
3 with IQR 2 (P = 0.002).
The changes in the NIRS-derived parameters of StO2
upslope and time to baseline were used as outcome vari-
ables in regression models which had as a single predictor
the following variables: NMES protocol, patient group
(acute or ICUAW), final current intensity, increase in
current intensity, strength of muscle contractions. In both
cases, the strength of the muscle contractions was the
variable that best predicted the changes of the parameter
during the NMES session (Table 5).
Table 2 Clinical and laboratory data of patients before and after the neuromuscular electrical stimulation (NMES) session
HF protocol (n = 17) MF protocol (n = 14)
Before NMES After NMES P Before NMES After NMES P
Hemodynamic parameters
Systolic BP (mmHg) 125 ± 19 130 ± 18 0.17 128 ± 19 135 ± 25 0.06
Diastolic BP (mmHg) 71 ± 11 74 ± 12 0.19 62 ± 9 65 ± 11 0.25
Heart rate (min-1) 97 ± 14 100 ± 17 0.18 93 ± 19 100 ± 18 0.01
Respiratory parameters
Respiratory rate (min-1) 22 ± 7 23 ± 6 0.4 22 ± 6 25 ± 9 0.04
SpO2 (%) 98 ± 1 98 ± 2 0.5 98 ± 1 98 ± 2 0.3
PaO2 (mmHg) 125 ± 39 121 ± 40 0.1 128 ± 30 121 ± 28 0.2
PaCO2 (mmHg) 36 ± 4 36 ± 9 0.9 36 ± 9 32 ± 3 0.6
ScvO2 (%) 74 ± 8 77 ± 6 0.08 78 ± 7 79 ± 5 0.6
Other
Temperature (°C) 37.1 ± 1.5 37.2 ± 1.5 0.5 37.7 ± 1,1 37.5 ± 1,1 0.04
Lactate (mEq/mL) 1.3 ± 0.4 1.5 ± 0.5 0.06 1.0 ± 0.5 1.4 ± 0.6 0.007
HF, high frequency; MF, medium frequency; PaCO2, partial pressure of carbon dioxide in arterial blood; PaO2, partial pressure of oxygen in arterial blood; SpO2,
oxygen saturation; ScvO2, central venous oxygen saturation.
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Of the 31 patients included in the study, only in seven-
teen were NIRS readings from the vastus lateralis tech-
nically feasible. In the rest, no NIRS signal could be
obtained, despite the fact that during the design of the
study we had anticipated the known factors that inter-
fere with the NIRS readings. Patients with and without
NIRS readings did not differ with respect to severity of
illness (APACHE II score 19 ± 5 versus 17 ± 3, P = 0.5
and SOFA score 7 ± 2 versus 6 ± 3, P = 0.3) and presence
of ICUAW (7/17 versus 5/14, P = 0.5). Patients with
NIRS readings, however, had somewhat stronger muscle
contractions with median 2 and IQR 2 versus median 1
and IQR 2 (P = 0.08). They also differed in their response
in the thenar NIRS measurements: the StO2 upslope in-
creased by 0.7 ± 0.9 versus 0.4 ± 0.8%/second, while time
to baseline decreased by 18 ± 22 versus 14 ± 22 seconds.
In the patients with NIRS measurements (10 in the
HF protocol and 7 in the MF protocol), the effects of
NMES on the microcirculation of the exercising muscle
did not differ between the two protocols. Baseline StO2
values in the vastus lateralis were 48 ± 19 units versusTable 3 Changes in microcirculatory parameters monitored b
occlusion test in the two neuromuscular electrical stimulation
HF protocol (n = 17)
Microcirculatory parameter Before After
Tissue oxygenation (StO2) 79 ± 10 77 ± 11
StO2 downslope (%/minute) 8.6 ± 2.2 9.9 ± 5.1
StO2 upslope (%/second) 2.7 ± 1.4 3.2 ± 1.7
Time to baseline (seconds) 160 ± 55 145 ± 49
Legend: HF, high frequency; MF, medium frequency: StO2, tissue oxygen saturation51 ± 17 units, respectively (P = 0.7). ΔStO2slope was 61 ±
6%/minute in the HF protocol and 69 ± 23%/minute in
the MF protocol (P = 0.5). ΔStO2min was 5 ± 4 units with
the HF protocol and 7 ± 4 units with the MF protocol
(P = 0.3). ΔStO2max was 6 ± 7 units with the HF protocol
and 5 ± 4 units with the MF protocol (P = 0.6).
All three measured microcirculatory parameters in the
exercising muscle differed between the acute and the
ICUAW group of patients. ΔStO2slope was 85 ± 27%/mi-
nute in the acute group and 42 ± 13%/minute in the
ICUAW group (P = 0.04). ΔStO2min was 8 ± 4 units in
the acute group and 3 ± 2 units in the ICUAW group
(P = 0.005). ΔStO2max was 8 ± 6 units in the acute group
and 3 ± 2 units in the ICUAW group (P = 0.04).
The strength of the muscle contractions correlated
well with the microcirculatory parameters (ΔStO2slope:
rs = 0.7 with P = 0.05; ΔStO2min: rs = 0.8 with P < 0.001;
ΔStO2max: rs = 0.6 with P = 0.01).
Discussion
In this study comparing the acute effects of two types of
NMES, the main finding was that both mediumy near-infrared spectroscopy and use of a vascular
(NMES) protocols
MF protocol (n = 14)
P Before After P
0.06 76 ± 10 75 ± 11 0.6
0.08 8.8 ± 3.8 9.9 ± 3.6 0.07
0.04 2.5 ± 1.4 3.1 ± 1.7 0.03
0.03 163 ± 37 144 ± 33 0.001
.
Table 4 Changes in microcirculatory parameters monitored by near-infrared spectroscopy and use of a vascular occlu-
sion test in the two patient groups
Acute group (n = 19) ICUAW group (n = 12)
Microcirculatory parameter Before After P Before After P
Tissue oxygenation (StO2) 78 ± 11 77 ± 11 0.2 76 ± 8 75 ± 8 0.4
StO2 downslope (%/minute) 8.6 ± 3.4 9.1 ± 3.1 0.4 9.4 ± 2.6 10.3 ± 3.6 0.1
StO2 upslope (%/second) 2.4 ± 1.4 2.8 ± 1.5 0.03 2.9 ± 1.3 3.6 ± 1.8 0.04
Time to baseline (seconds) 160 ± 48 144 ± 47 0.003 162 ± 47 147 ± 34 0.04
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changes of similar magnitude on the systemic and local skel-
etal muscle microcirculation of critically ill patients. More-
over, the safety profile was equally good for the two types.
The application of NMES in critically ill patients is
relatively new. There is evidence that NMES can prevent
loss of muscle mass and strength in these patients
[11-13,15]. This suggests that it could be a viable option
for the prevention or the amelioration of ICUAW
[14,35]. There is one study that showed systemic effects
of a single NMES session on skeletal muscle microcircu-
lation [16]. Microcirculatory alterations are a hallmark
of sepsis, so these effects could mediate the beneficial ef-
fects observed in the skeletal muscle of septic patients.
One unresolved aspect of NMES use in the critically
ill is the optimal frequency of the applied current. Exist-
ing studies have used frequencies at the medium (45 to
50 Hz) and the high range (70 to 100 Hz). The only
study that examined acute systemic effects used a 45 Hz
current [16]. There is no study that examines the sys-
temic and local effects of both medium and high fre-
quency currents. To the extent that their effects are
mediated by effects on the microcirculation level, such a
comparison is of considerable interest.
This study confirmed that NMES improved endothe-
lial reactivity in a peripheral skeletal muscle not directlyFigure 1 Change scores in thenar muscle tissue oxygen
saturation (StO2) as measured by near-infrared spectroscopy
(NIRS) for each neuromuscular electrical stimulation (NMES)
protocol and patient group combination. Scores are calculated as
before minus after values.involved in the exercise. This effect has been ascribed to
the systemic action of muscle-derived cytokines, mainly
interleukin-6 (IL-6), whose levels are known to increase
during exercise [36-38]. Both current frequencies dis-
played this ability to a similar degree.
The two protocols also demonstrated the capacity to
improve the vascular reserve of the microcirculation.
This is related to the magnitude of capillary recruitment
after an ischemic challenge. Sympathetic activation and
its effects on vascular tone might be at the origin of this
phenomenon [39].
Local O2 consumption rate has been shown to in-
crease during NMES in a previous study [16]. This is in
line with other studies which have showed that NMES
increases O2 uptake in healthy volunteers [40-42] and in
COPD patients [43]. In fact, in a direct comparison of
two types of NMES with frequencies of 15 Hz and
75 Hz both types of NMES were able to increase ventila-
tion and O2 uptake in COPD patients [44]. In the
present study we observed an increase of the local
muscle O2 consumption rate of similar degree in both
NMES protocols, and also in both patient groups. How-
ever, our observed effect was less than that reported by
Gerovasili et al. [16]. This might account for the lack ofFigure 2 Change scores in thenar muscle oxygen consumption
rate (tissue oxygen saturation (StO2) downslope) as measured
by near-infrared spectroscopy (NIRS) during a vascular
occlusion test for each neuromuscular electrical stimulation
(NMES) protocol and patient group combination. Scores are
calculated as before minus after values.
Figure 3 Change scores in thenar muscle endothelial reactivity
(tissue oxygen saturation (StO2) upslope) as measured by near-
infrared spectroscopy (NIRS) during a vascular occlusion test
for each neuromuscular electrical stimulation (NMES) protocol
and patient group combination. Scores are calculated as before
minus after values.
Table 5 The Akaike Information Criterion for regression
models with change in microcirculatory parameters
during neuromuscular electrical stimulation (NMES) as
the outcome variable, and those listed in each line of the
table as the predictor
Variable StO2 upslope Time to baseline
NMES protocol 99.38 266.18
Patient group 94.78 266.43
Final current intensity 97.94 266.44
Increase in current intensity 96.38 265.75
Strength of muscle contractions 74.92 214.28
StO2, tissue oxygen saturation.
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a similar sample size.
A related finding of clinical relevance was that the de-
gree of the changes in the microcirculation seems to be
related to the quality of the muscular contractions. This
would imply that any beneficial effects that NMES derive
from the exercising muscle. It also advocates the timely
application of NMES during critical illness.
As far as the local microcirculation of the exercising
muscle is concerned, the results of this study were entirely
analogous to the systemic case. NMES using pulsed currents
of medium and high frequency have very similar effects.
ΔStO2slope during a contraction reflects the oxidative
energetic cost of muscle activation [32,45]. This inter-
pretation rests on the assumption that an isometric con-
traction above 25 to 35% of maximal voluntaryFigure 4 Change scores in thenar muscle vascular reserve (time
to baseline tissue oxygen saturation (StO2) value) as measured
by near-infrared spectroscopy (NIRS)_during a vascular occlusion
test for each neuromuscular electrical stimulation (NMES)
protocol and patient group combination. Scores are calculated as
before minus after values.contraction blocks or severely limits arterial inflow and
O2 delivery because of the increased intramuscular pres-
sure [46]. The two protocols under study achieved
muscle contractions of comparable strength, which is a
plausible explanation for this finding. Although ours is
the first study directly comparing two types of NMES,
there are two previous studies by the same research
group that have separately compared voluntary contrac-
tions with two NMES protocols using different frequen-
cies for each comparison. They examined the biceps
brachii muscle and they used a NIRS device identical to
the one used in the present study to evaluate oxygen-
ation. They concluded that local O2 demand during a
NMES-induced isometric contraction of 30 seconds was
similar in using a 30 Hz and a 75 Hz current [47,48].
ΔStO2min values were also similar in the two protocols.
This parameter reflects the dynamic equilibrium be-
tween O2 demand and O2 delivery to the volume of
muscle illuminated by the NIRS probe. This equilibrium
is affected by several factors such as the mechanical
pressure on vessels during contraction, blood flow and
consequently blood volume, venous return, relative de-
gree of vasoconstriction and vasodilation in the micro-
circulation [49,50]. Our findings indicate that O2
consumption increased relatively to O2 delivery to a
similar extent with the two types of current.
These parameters correlated well with the strength of
muscle contractions. This can also be explained by the
physiology of contraction and the transmission of pres-
sures to the interior of the vasculature. It is also in
agreement with a previous study which showed that O2
consumption estimated by NIRS in the biceps brachii
during isometric contractions increases proportionally to
the force developed from 20 to 80% of maximal volun-
tary contraction [32].
NMES showed an excellent safety profile in our study.
Biochemical monitoring for muscle injury showed no
adverse effects in an extended follow-up. This is in
agreement with recent results that confirm the safety of
NMES application [51,52].
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http://www.annalsofintensivecare.com/content/3/1/39The main limitation of this study was the small num-
ber of patients with NIRS measurements of the vastus
lateralis muscle. These patients were clinically similar to
those from whom a signal could be obtained; however, a
difference was found in contracting ability. It remains to
be clarified if the inability to detect a NIRS signal was
due to some muscle characteristic that also interfered
with contractions or with the passage of current through
tissue. It is possible that this difference in contractile
ability reflects local factors (for example, tissue edema)
not clinically identifiable, but correlated with more dis-
eased muscle and this cannot be captured by the con-
ventional scales that measure disease severity, such as
the SOFA score. Another limitation is that by design we
examined only short-term effects of NMES on the
microcirculation. These effects might well be short-lived,
so that repeated applications of NMES might be re-
quired. Frequency of application and overall duration of
NMES treatment were outside the scope of our protocol;
further studies should address these issues.
Conclusion
We could not find differences in the effects that a ses-
sion of NMES with medium and high frequencies has on
skeletal muscle microcirculatory function, both at the
systemic and local level. Further studies are needed to
compare the effects of the two types on clinical out-
comes related to muscle function and the development
of ICUAW.
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